Understanding human papilloma virus vaccine uptake.
Fisher, W. A., (2012). Understanding human papilloma virus vaccine uptake. Vaccine, 30S, F149-F156.
Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
Gallagher, K. E., Howard, N., Kabakama, S., Mounier-Jack, S., Burchett, H. E. D., LaMontagne, D. S., & Watson-Jones, D., (2017). Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016. Papillomavirus Research, 4, 72-78.
Vaccine programme stakeholder perspectives on a hypothetical single-dose human papilloma virus (HPV) vaccine schedule in low and middle-income countries.
Gallagher, K. E., Kelly, H., Cocks, N., Dixon, S., Mounier-Jack, S., Howard, N., & Watson-Jones, D., (2018). Vaccine programme stakeholder perspectives on a hypothetical single-dose human papilloma virus (HPV) vaccine schedule in low and middle-income countries. Papillomavirus Research, 6, 33-40.
“HPV? Never heard of it!”: A systematic review of girls’ and parents’ information needs, views and preferences about human papilloma virus vaccination.
Hendry, M., Lewis, R., Clements, A., Damery, S., & Wilkinson, C., (2013). “HPV? Never heard of it!”: A systematic review of girls’ and parents’ information needs, views and preferences about human papilloma virus vaccination. Vaccine, 31, 5152-5167.
Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States.
Chesson, H. W., Meites, E., Ekwueme, D. U., Saraiya, M., & Markowitz, L. E., (2018). Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States. Vaccine, 36, 4362-4368.
Human papillomavirus (HPV) vaccine initiation in minority Americans.
De, P., & Budhwani, H., (2017). Human papillomavirus (HPV) vaccine initiation in minority Americans. Public Health, 144, 86-91.
Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice.
Brown, B., Gabra, M. I., & Pellman, H., (2017). Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice. Papillomavirus Research, 3, 42-45.
Social determinants of HPV vaccination delay rationales: Evidence from the 2011 National Immunization Survey-Teen.
Burdette, A. M., Gordon-Jokinen, H., & Hill, T. D., (2014). Social determinants of HPV vaccination delay rationales: Evidence from the 2011 National Immunization Survey-Teen. Preventive Medicine Reports, 1, 21-26.
Evaluation of paediatric human papilloma virus vaccination provider counseling written materials: A health literacy perspective.
Chhabra, R., Chisolm, D. J., Bayldon, B., Quadri, M., Sharif, I.,Velazquez, J. J., … & Yin, S., (2018). Evaluation of paediatric human papilloma virus vaccination provider counseling written materials: A health literacy perspective. Academic Pediatric Association, 18(2S), S28-S36.
Increasing parental knowledge related to the human papilloma virus (HPV) vaccine.
Cipriano, J. J., Scoloveno, R., & Kelly, A., (2018). Increasing parental knowledge related to the human papilloma virus (HPV) vaccine. Journal of Pediatric Health Care, 32(1), 29-35.
